Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Zika Virus Infection RIG-ged by Keratinocytes and Fibroblasts.

Dupin N, Piguet V.

J Invest Dermatol. 2019 Feb;139(2):281-282. doi: 10.1016/j.jid.2018.09.003.

PMID:
30665581
2.

Efficacy of Off-Label Topical Treatments for the Management of Androgenetic Alopecia: A Review.

Gupta AK, Mays RR, Versteeg SG, Shear NH, Piguet V, Piraccini BM.

Clin Drug Investig. 2019 Mar;39(3):233-239. doi: 10.1007/s40261-018-00743-8. Review.

PMID:
30652260
3.

Safety Issues of Pharmacological Acute Pain Treatment in Children.

Rodieux F, Piguet V, Desmeules J, Samer CF.

Clin Pharmacol Ther. 2019 Jan 16. doi: 10.1002/cpt.1358. [Epub ahead of print] Review.

PMID:
30648741
4.

The Efficacy of Platelet-Rich Plasma in the Field of Hair Restoration and Facial Aesthetics-A Systematic Review and Meta-analysis.

Gupta AK, Versteeg SG, Rapaport J, Hausauer AK, Shear NH, Piguet V.

J Cutan Med Surg. 2019 Mar/Apr;23(2):185-203. doi: 10.1177/1203475418818073. Epub 2019 Jan 4.

PMID:
30606055
5.

Global perspectives for the management of onychomycosis.

Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Takwale A, Shemer A, Babaev M, Grover C, Di Chiacchio NG, Taborda PRO, Taborda VBA, Shear NH, Piguet V, Tosti A.

Int J Dermatol. 2018 Dec 25. doi: 10.1111/ijd.14346. [Epub ahead of print] Review.

PMID:
30585300
6.

British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018.

Ingram JR, Collier F, Brown D, Burton T, Burton J, Chin MF, Desai N, Goodacre TEE, Piguet V, Pink AE, Exton LS, Mohd Mustapa MF.

Br J Dermatol. 2018 Dec 15. doi: 10.1111/bjd.17537. [Epub ahead of print] No abstract available.

PMID:
30552762
7.

Dermatomyositis: a slow path towards targeted therapies or will conventional therapies prevail?

Piguet V, Choy E.

Br J Dermatol. 2018 Dec;179(6):1233-1234. doi: 10.1111/bjd.16230. No abstract available.

PMID:
30508240
8.

Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017.

Shavit E, Alavi A, Bechara FG, Bennett RG, Bourcier M, Cibotti R, Daveluy S, Frew JW, Garg A, Hamzavi I, Hoffman LK, Hsaio J, Kirby JS, Lev-Tov H, Martinez E, Micheletti R, Naik HB, Nassif A, Nicholson C, Parks-Miller A, Patel Z, Piguet V, Ramesh M, Resnik B, Sayed C, Schultz G, Siddiqui A, Tan J, Wortsman X, Lowes MA.

Exp Dermatol. 2019 Jan;28(1):94-103. doi: 10.1111/exd.13849.

PMID:
30484907
9.

A Practical Guide to Curing Onychomycosis: How to Maximize Cure at the Patient, Organism, Treatment, and Environmental Level.

Gupta AK, Versteeg SG, Shear NH, Piguet V, Tosti A, Piraccini BM.

Am J Clin Dermatol. 2019 Feb;20(1):123-133. doi: 10.1007/s40257-018-0403-4.

PMID:
30456537
10.

Are Bacteria Infectious Pathogens in Hidradenitis Suppurativa? Debate at the Symposium for Hidradenitis Suppurativa Advances Meeting, November 2017.

Naik HB, Nassif A, Ramesh MS, Schultz G, Piguet V, Alavi A, Lowes MA.

J Invest Dermatol. 2019 Jan;139(1):13-16. doi: 10.1016/j.jid.2018.09.036. Epub 2018 Nov 8.

PMID:
30414909
11.

Update on current approaches to diagnosis and treatment of onychomycosis.

Gupta AK, Mays RR, Versteeg SG, Shear NH, Piguet V.

Expert Rev Anti Infect Ther. 2018 Dec;16(12):929-938. doi: 10.1080/14787210.2018.1544891. Epub 2018 Nov 13. Review.

PMID:
30411650
12.

Pyoderma gangrenosum and its impact on quality of life: a multicentre, prospective study.

Ighani A, Al-Mutairi D, Rahmani A, Weizman AV, Piguet V, Alavi A.

Br J Dermatol. 2019 Mar;180(3):672-673. doi: 10.1111/bjd.17347. Epub 2018 Nov 23. No abstract available.

PMID:
30362501
13.

Masters of manipulation: Viral modulation of the immunological synapse.

Bayliss RJ, Piguet V.

Cell Microbiol. 2018 Oct;20(10):e12944. doi: 10.1111/cmi.12944. Review.

PMID:
30123959
14.

Dendritic Cells Promote the Spread of Human T-Cell Leukemia Virus Type 1 via Bidirectional Interactions with CD4+ T Cells.

Shimauchi T, Caucheteux S, Finsterbusch K, Turpin J, Blanchet F, Ladell K, Triantafilou K, Czubala M, Tatsuno K, Easter T, Ahmed Z, Bayliss R, Hakobyan S, Price DA, Tokura Y, Piguet V.

J Invest Dermatol. 2019 Jan;139(1):157-166. doi: 10.1016/j.jid.2018.06.188. Epub 2018 Jul 23.

PMID:
30048652
15.

Vaginal epidermal dendritic cells: defense against HIV-1 or a safe haven?

Caucheteux S, Piguet V.

J Clin Invest. 2018 Aug 1;128(8):3228-3230. doi: 10.1172/JCI121744. Epub 2018 Jul 9.

16.

[Pain management in adult medico-surgical wards : practical guidelines].

Luthy C, Chaves-Iselin I, Kupferschmid S, Bollondi-Pauly C, Pautex S, Escher M, Broers B, Rehberg-Klug B, Cedraschi C, Piguet V.

Rev Med Suisse. 2018 Jun 20;14(612):1296-1300. French.

PMID:
29944297
17.

[Opioids prescription in the vulnerable populations : the children and the elderly. Practical guidelines].

Rodieux F, Lloret-Linares C, Piguet V, Desmeules J.

Rev Med Suisse. 2018 Jun 20;14(612):1268-1278. French.

PMID:
29944293
18.

Tinea capitis in children: a systematic review of management.

Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Shear NH, Piguet V, Tosti A, Friedlander SF.

J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2264-2274. doi: 10.1111/jdv.15088. Epub 2018 Jul 12.

PMID:
29797669
19.

Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.

Gupta AK, Mays RR, Dotzert MS, Versteeg SG, Shear NH, Piguet V.

J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2112-2125. doi: 10.1111/jdv.15081. Epub 2018 Jul 11.

PMID:
29797431
20.

Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT).

Lebwohl M, Blauvelt A, Paul C, Sofen H, Węgłowska J, Piguet V, Burge D, Rolleri R, Drew J, Peterson L, Augustin M.

J Am Acad Dermatol. 2018 Aug;79(2):266-276.e5. doi: 10.1016/j.jaad.2018.04.013. Epub 2018 Apr 14.

21.

Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.

Cooksey R, Brophy S, Kennedy J, Gutierrez FF, Pickles T, Davies R, Piguet V, Choy E.

Semin Arthritis Rheum. 2018 Dec;48(3):367-373. doi: 10.1016/j.semarthrit.2018.03.005. Epub 2018 Mar 17.

22.

When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children.

Rodieux F, Vutskits L, Posfay-Barbe KM, Habre W, Piguet V, Desmeules JA, Samer CF.

Front Pharmacol. 2018 Mar 5;9:148. doi: 10.3389/fphar.2018.00148. eCollection 2018. Review.

23.

Hot Stuff: Thermal Imaging Aids in Cellulitis Diagnosis.

Drucker AM, Piguet V.

J Invest Dermatol. 2018 Mar;138(3):482-484. doi: 10.1016/j.jid.2017.10.008.

24.

The Ticking CLOCK of HSV-2 Pathology.

Bayliss RJ, Piguet V.

J Invest Dermatol. 2018 Jan;138(1):17-19. doi: 10.1016/j.jid.2017.08.028.

25.

Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study.

Reich K, Gooderham M, Bewley A, Green L, Soung J, Petric R, Marcsisin J, Cirulli J, Chen R, Piguet V.

J Eur Acad Dermatol Venereol. 2018 Mar;32(3):397-402. doi: 10.1111/jdv.14738. Epub 2018 Jan 29.

26.

Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa.

Ingram JR, Jenkins-Jones S, Knipe DW, Morgan CLI, Cannings-John R, Piguet V.

Br J Dermatol. 2018 Apr;178(4):917-924. doi: 10.1111/bjd.16101. Epub 2018 Feb 22.

PMID:
29094346
27.

How to Train to Discharge a Dermatology Outpatient: A Review.

Harun A, Finlay AY, Salek MS, Piguet V.

Dermatology. 2017;233(4):260-267. doi: 10.1159/000479060. Epub 2017 Oct 10. Review.

28.

Evaluation of port site hernias, chronic pain and recurrence rates after laparoscopic ventral hernia repair: a monocentric long-term study.

Liot E, Bréguet R, Piguet V, Ris F, Volonté F, Morel P.

Hernia. 2017 Dec;21(6):917-923. doi: 10.1007/s10029-017-1663-2. Epub 2017 Sep 1.

PMID:
28864912
29.

Levels of wound calprotectin and other inflammatory biomarkers aid in deciding which patients with a diabetic foot ulcer need antibiotic therapy (INDUCE study).

Ingram JR, Cawley S, Coulman E, Gregory C, Thomas-Jones E, Pickles T, Cannings-John R, Francis NA, Harding K, Hood K, Piguet V.

Diabet Med. 2018 Feb;35(2):255-261. doi: 10.1111/dme.13431. Epub 2017 Aug 15.

30.

Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression.

Ali FM, Kay R, Finlay AY, Piguet V, Kupfer J, Dalgard F, Salek MS.

Qual Life Res. 2017 Nov;26(11):3025-3034. doi: 10.1007/s11136-017-1607-4. Epub 2017 Jun 10.

31.

The pathogenesis of dermatomyositis.

Thompson C, Piguet V, Choy E.

Br J Dermatol. 2018 Dec;179(6):1256-1262. doi: 10.1111/bjd.15607. Epub 2017 May 24. Review.

PMID:
28542733
32.

Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.

Collins PJ, McCully ML, Martínez-Muñoz L, Santiago C, Wheeldon J, Caucheteux S, Thelen S, Cecchinato V, Laufer JM, Purvanov V, Monneau YR, Lortat-Jacob H, Legler DF, Uguccioni M, Thelen M, Piguet V, Mellado M, Moser B.

FASEB J. 2017 Jul;31(7):3084-3097. doi: 10.1096/fj.201700013R. Epub 2017 Mar 30.

33.

Heat-Induced Editing of HPV Genes to Clear Mucocutaneous Warts?

Piguet V.

J Invest Dermatol. 2017 Apr;137(4):796-797. doi: 10.1016/j.jid.2017.01.015.

34.

Dermatology Life Quality Index (DLQI) as a psoriasis referral triage tool.

Atwan A, Piguet V, Finlay AY, Francis NA, Ingram JR.

Br J Dermatol. 2017 Oct;177(4):e136-e137. doi: 10.1111/bjd.15446. Epub 2017 Sep 19. No abstract available.

PMID:
28295196
35.

Understanding clinician influences and patient perspectives on outpatient discharge decisions: a qualitative study.

Harun NA, Finlay AY, Piguet V, Salek S.

BMJ Open. 2017 Mar 6;7(3):e010807. doi: 10.1136/bmjopen-2015-010807.

36.

Bedside or not bedside: Evaluation of patient satisfaction in intensive medical rehabilitation wards.

Luthy C, Francis Gerstel P, Pugliesi A, Piguet V, Allaz AF, Cedraschi C.

PLoS One. 2017 Feb 7;12(2):e0170474. doi: 10.1371/journal.pone.0170474. eCollection 2017.

37.

Comparison of the paper-based and electronic versions of the Dermatology Life Quality Index: evidence of equivalence.

Ali FM, Johns N, Finlay AY, Salek MS, Piguet V.

Br J Dermatol. 2017 Nov;177(5):1306-1315. doi: 10.1111/bjd.15314. Epub 2017 Jun 12.

PMID:
28112800
38.

Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments.

Atwan A, Ingram JR, Abbott R, Kelson MJ, Pickles T, Bauer A, Piguet V.

Br J Dermatol. 2016 Nov;175(5):873-881. doi: 10.1111/bjd.14676. Epub 2016 Aug 29. Review.

39.

New Cutaneous Vaccine Adjuvant that STINGs a Little Less.

Caucheteux SM, Piguet V.

J Invest Dermatol. 2016 Nov;136(11):2127-2128. doi: 10.1016/j.jid.2016.07.020. Review.

40.

The efficacy and safety of apremilast, etanercept and placebo in patients with moderate-to-severe plaque psoriasis: 52-week results from a phase IIIb, randomized, placebo-controlled trial (LIBERATE).

Reich K, Gooderham M, Green L, Bewley A, Zhang Z, Khanskaya I, Day RM, Goncalves J, Shah K, Piguet V, Soung J.

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):507-517. doi: 10.1111/jdv.14015. Epub 2016 Dec 19.

41.

Juvenile dermatomyositis: new clinical trial evidence to underpin therapeutic shared decision making.

Owen ED, Choy EH, Piguet V.

Br J Dermatol. 2016 Oct;175(4):665-6. doi: 10.1111/bjd.14917. No abstract available.

PMID:
27650736
42.

Image Gallery: Pseudoepitheliomatous hyperplasia, a rare tattoo reaction.

Kiss F, May K, Piguet V.

Br J Dermatol. 2016 Sep;175(3):e112. doi: 10.1111/bjd.14853. No abstract available.

PMID:
27632970
43.

[It is not only about cost ... when it comes to generic medication].

Piguet V, D'Incau S, Besson M, Desmeules J, Cedraschi C.

Rev Med Suisse. 2016 Jun 22;12(524):1230-3. French.

PMID:
27506067
44.

TGFβ Induces a SAMHD1-Independent Post-Entry Restriction to HIV-1 Infection of Human Epithelial Langerhans Cells.

Czubala MA, Finsterbusch K, Ivory MO, Mitchell JP, Ahmed Z, Shimauchi T, Karoo ROS, Coulman SA, Gateley C, Birchall JC, Blanchet FP, Piguet V.

J Invest Dermatol. 2016 Oct;136(10):1981-1989. doi: 10.1016/j.jid.2016.05.123. Epub 2016 Jun 29.

45.

HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells.

Coulon PG, Richetta C, Rouers A, Blanchet FP, Urrutia A, Guerbois M, Piguet V, Theodorou I, Bet A, Schwartz O, Tangy F, Graff-Dubois S, Cardinaud S, Moris A.

J Immunol. 2016 Jul 15;197(2):517-32. doi: 10.4049/jimmunol.1600286. Epub 2016 Jun 10.

46.

A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.

Ali FM, Cueva AC, Vyas J, Atwan AA, Salek MS, Finlay AY, Piguet V.

Br J Dermatol. 2017 Mar;176(3):577-593. doi: 10.1111/bjd.14788. Epub 2016 Oct 12. Review.

PMID:
27273146
47.

Treatment of clinically amyopathic dermatomyositis in adults: a systematic review.

Callander J, Robson Y, Ingram J, Piguet V.

Br J Dermatol. 2018 Dec;179(6):1248-1255. doi: 10.1111/bjd.14726. Epub 2016 Aug 30. Review.

PMID:
27167896
48.

The development and clinical evaluation of a 'traffic-light' design dermatology outpatient discharge information checklist.

Harun NA, Finlay AY, Salek M, Piguet V.

Br J Dermatol. 2016 Sep;175(3):572-82. doi: 10.1111/bjd.14650. Epub 2016 Aug 23.

PMID:
27060980
49.

Polypropylene Sulfide Nanoparticle p24 Vaccine Promotes Dendritic Cell-Mediated Specific Immune Responses against HIV-1.

Caucheteux SM, Mitchell JP, Ivory MO, Hirosue S, Hakobyan S, Dolton G, Ladell K, Miners K, Price DA, Kan-Mitchell J, Sewell AK, Nestle F, Moris A, Karoo RO, Birchall JC, Swartz MA, Hubbel JA, Blanchet FP, Piguet V.

J Invest Dermatol. 2016 Jun;136(6):1172-1181. doi: 10.1016/j.jid.2016.01.033. Epub 2016 Feb 16.

50.

Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process.

Ingram JR, Hadjieconomou S, Piguet V.

Br J Dermatol. 2016 Aug;175(2):263-72. doi: 10.1111/bjd.14475. Epub 2016 May 2. Review.

PMID:
26873867

Supplemental Content

Loading ...
Support Center